No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Twice-Yearly Lenacapavir is Effective for Human Immunodeficiency Virus Prevention in Men and Gender-Diverse Persons

byAstrid BradshawandAlisha Yi

December 11, 2024

in StudyGraphics

Reading Time: 1 min read

Click here to read this study in NEJM.

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Weekly islatravir plus lenacapavir maintains HIV virologic suppression

Ending Ryan White services may increase human immunodeficiency virus incidence

Increased risk of low birth weight and adverse pregnancy outcomes among women living with HIV

Inavolisib lengthens progression-free survival time in HER2-negative advanced breast cancer

RelatedReports

Few high school students, young adults get HIV testing

Chronic Disease

Weekly islatravir plus lenacapavir maintains HIV virologic suppression

December 22, 2025

Institute of Medicine identifies cost variation between geographic regions

Infectious Disease

Ending Ryan White services may increase human immunodeficiency virus incidence

September 8, 2025

Chronic Disease

Increased risk of low birth weight and adverse pregnancy outcomes among women living with HIV

August 22, 2025

Chronic Disease

Psychiatric and physical comorbidities continue to be prevalent amongst Canadians living with Human Immunodeficiency Virus

July 21, 2025

Maternal cell-free DNA sequencing superior to standard aneuploidy screening [CARE Study]

Australian couple-based genetic screening program feasible and accepted

Compliance-linked incentives increase infant immunizations rates in rural India

Reduced pneumococcal vaccine schedules non-inferior to WHO recommendations

Stroke expansion following intra-arterial therapy may explain worse outcomes

Early oral anticoagulation is non-inferior to delayed treatment in patients with ischemic stroke and atrial fibrillation

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result